PerpEquitiesReference market
Closed- Regular hours
- 09:30 AM – 04:00 PM
- Next holiday
- Nov 26, 2026 · Thanksgiving Day
Equity
Hims & Hers Health, Inc. (HIMS) perpetual futures
HIMS perpetual futures on 18 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade HIMSUSDT.
Hims & Hers Health operates a digital health platform connecting consumers with licensed professionals for virtual care and wellness products.
$28.76-2.2%NYSE closed
Price chart
–
Use the left and right arrow keys to inspect points on the chart.
Collecting venue price data...
venue perp mark · LBank (HIMS/USDT)
Auto: highest-volume live perp venueOpen in TradingView
Trading data
Perpetual market activity
18/18 live markets
Trading data
Perpetual market activity
Venues
18
Live markets
18/18
24h volume
$9.7MCoverage: 13/18 marketsExchange-reported volume: $17.6M
Open interest
$50.7MCoverage: 13/18 markets
Best liquidity
$1.5M
Ourbit
Tightest spread
+3.5 bps
Ourbit
Highest volume
$6.5M
LBank
Settlement mix
USDT · 14/18
Perp/spot vol.
0.05x
Spot volume $185.8M
OI / float
+0.84%
Float $6B
Spot performance
1D-2.18%
5D-5.33%
1M-0.21%
6M+48.50%
YTD-11.36%
1Y-51.32%
Venue matrix
18 markets
Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.
| Trade | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 LBank | Trade | HIMS/USDT | Trading | $28.77 | 0.0% APR 0.000% every 8h | - | - | $6.5M | - | USDT | 50x | |
 Hyperliquid HIP-3 | Trade | xyz:HIMS | Trading | $28.75 | +12.0% APR +0.00137% every 1h | +9.7 bps | $52.9K | $1.1M | $3M | USDC | 10x | |
 Deepcoin | Trade | HIMS/USDT | Trading | $28.77 | -11.0% APR -0.010% every 8h | +3.5 bps | $167.5K | $876.8K | - | USDT | 25x | |
 Gate.io | Trade | HIMS/USDT | Trading | $28.77 | 0.0% APR 0.000% every 8h | +28.5 bps | $7.9K | $256.6K | $460K | USDT | 25x | |
 XT.com | Trade | HIMS/USDT | Trading | $28.77 | +11.0% APR +0.010% every 8h | +17.4 bps | $2.7K | $251K | $45.1M | USDT | 20x | |
 Bitunix | Trade | HIMS/USDT | Trading | $28.77 | -0.5% APR -0.00046% every 8h | +17.4 bps | $772K | $185.7K | - | USDT | 20x | |
 OKX | Trade | HIMS/USDT | Trading | $28.77 | 0.0% APR 0.000% every 8h | +17.4 bps | $21.5K | $146.5K | $293.7K | USDT | 20x | |
 MEXC | Trade | HIMS/USDT | Trading | $28.77 | 0.0% APR 0.000% every 8h | +3.5 bps | $330.7K | $115.7K | $206.3K | USDT | 50x | |
 Bybit | Trade | HIMS/USDT | Trading | $28.77 | 0.0% APR 0.000% every 8h | +17.4 bps | $9.8K | $86.9K | $330.4K | USDT | 25x | |
 HTX | Trade | HIMS/USDT | Trading | $28.68 | 0.0% APR 0.000% every 8h | +116.8 bps | $1.1K | $61.4K | $5.7K | USDT | - | |
 Helix (Injective) | Trade | HIMS/USDC | Trading | $28.75 | +24.1% APR +0.00275% every 1h | +741.5 bps | $0 | $54.8K | - | USDC | 6x | |
 Crypto.com Exchange | Trade | HIMS/USD | Trading | $28.77 | +54.4% APR +0.00621% every 1h | +41.8 bps | $3.9K | $3.9K | $4.4K | USD | 50x | |
 Aster | Trade | HIMSUSDT | Trading | $28.77 | 0.0% APR 0.000% every 8h | +114.7 bps | $133.3K | $3.4K | $2.6K | USDT | - | |
 Vest | Trade | HIMS/USDC | Trading | $28.79 | +5.0% APR +0.00057% every 1h | +48.8 bps | $564.6K | - | - | USDC | 10x | |
 Binance | Trade | HIMS/USDT | Trading | $28.77 | 0.0% APR 0.000% every 8h | +3.5 bps | $232.1K | $3.6M⚠ | $927K | USDT | - | |
 Ourbit | Trade | HIMS/USDT | Trading | $28.76 | 0.0% APR 0.000% every 8h | +3.5 bps | $1.5M | $1.8M⚠ | $164.1K | USDT | 50x | |
 KuCoin | Trade | HIMS/USDT | Trading | $28.77 | 0.0% APR 0.000% every 8h | +17.4 bps | $7.3K | $1.3M⚠ | $134.6K | USDT | 20x | |
 BingX | Trade | HIMS-USDT | Trading | $28.77 | +5.5% APR +0.00500% every 8h | +17.4 bps | $344.3K | $1.3M⚠ | $2.7K | USDT | - |
Unverified volume: implausibly high against open interest, a typical sign of wash trading. These venues are listed last.
Tokenized wrappers of the real stock, tradable on-chain and on crypto exchanges around the clock. Premium/discount compares the token price to our stock reference price. Data: CoinMarketCap · Robinhood · DexScreener · GeckoTerminal.
| Product | Price | Premium vs stock | 24h Vol. | Market Cap | Chains |
|---|---|---|---|---|---|
| HIMSTokenized | $28.66 | -0.36% | $3.8M | – | Robinhood Chain |
| HIMSRobinhood | $28.73 | -0.10% | $2.2M | $3.2M | Robinhood Chain |
| HIMSonOndo GM | $28.70 | -0.21% | $2.2M | $30.3M | Ethereum · BNB Smart Chain (BEP20) · Solana |
| HIMSBbStocks | $28.67 | -0.31% | $189k | $748k | BNB Smart Chain (BEP20) |
| HIMSxxStocks | $28.67 | -0.33% | $16k | $445k | Solana · Ethereum · Mantle · Arbitrum |
| Exchange | Pair | Price | 24h Vol. | Liquidity |
|---|---|---|---|---|
 uniswapDEX · robinhood | HIMS/SPY ↗ | $28.73 | $2.2M | $332k |
| uniswapDEX · robinhood | HIMS/BONER ↗ | – | – | – |
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100k
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100kBroad liquidity · 10 of 18 venues absorb $10k · Typical cost: +12.5 bps – +24.7 bps
Too thin: Gate.io, KuCoin, Crypto.com Exchange, XT.com
No fresh book data: Aster, HTX, LBank, Helix (Injective)
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Best venues for this underlying
Best liquidity
HIMSTightest spread
HIMSHighest volume
HIMSFunding history
Stored venue snapshots by market
Funding history
Stored venue snapshots by marketCompany data
Company fundamentals
Updated 3h ago
Company data
Company fundamentals
Market cap
$6.4B
Updated 3h ago
Revenue
$2.6B
Trailing 12 months
Revenue growth
+37%
Next fiscal year
Profit margin
-5.5%
P/E
-47.2
Peer P/E 11.8
Free cash flow
$89.9M
Trailing 12 months
More metrics
Net income
-$142M
Trailing 12 months
P/S
2.5
Peer P/E
11.8
Similar listed perps
Revenue estimate
$3.2B
Next fiscal year
Earnings
2026-11-09
Revenue est. $892.6M · Updated 3h ago
Dividend
-
Fundamental detail
Annual + quarterlyLatest revenue$2.3B
Net margin+5.5%
Free cash flow$74M
Net debt$892M
PeriodRevenueGrowthNet incomeFCF
2020$148.8M+80%-$18.1M-$6.7M
2021$271.9M+83%-$107.7M-$39.4M
2022$526.9M+94%-$65.7M-$33.8M
2023$872M+65%-$23.5M$47M
2024$1.5B+69%$126M$198.3M
2025$2.3B+59%$128.4M$74M
PeriodGross marginOperating marginNet marginROEROA
2020+73.6%-10.2%-12.2%+12.3%-15.3%
2021+75.2%-42.3%-39.6%-32.2%-25.6%
2022+77.6%-13.0%-12.5%-21.1%-17.9%
2023+82.0%-3.4%-2.7%-6.8%-5.3%
2024+79.5%+4.2%+8.5%+26.4%+17.8%
2025+73.8%+4.5%+5.5%+23.7%+6.0%
PeriodCashDebtNet debtCurrent ratio
2020$27.3M$0-$27.3M7.43
2021$71.8M$5.5M-$66.3M3.41
2022$46.8M$5.3M-$41.5M4.52
2023$96.7M$9.9M-$86.7M3.00
2024$220.6M$11.3M-$209.2M1.79
2025$228.6M$1.1B$892M1.90
PeriodMarket capEnterprise valueP/SP/E
2020$516.2M$488.8M3.5-28.6
2021$1.2B$1.2B4.5-11.3
2022$1.3B$1.3B2.5-20.0
2023$1.9B$1.8B2.1-80.9
2024$5.2B$5B3.541.7
2025$7.3B$8.2B3.157.0
PeriodRevenueGrowthNet incomeFCF
Q3 2024$401.6M+77%$75.6M$79.4M
Q4 2024$481.1M+95%$26M$59.5M
Q1 2025$586M+111%$49.5M$50.1M
Q2 2025$544.8M+73%$42.5M-$69.4M
Q3 2025$599M+49%$15.8M$91.4M
Q4 2025$617.8M+28%$20.6M$821K
Q1 2026$608.1M+4%-$92.1M$53M
Q2 2026$753.2M+38%-$86.3M-$55.4M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+79.2%+5.6%+18.8%+17.2%+12.6%
Q4 2024+76.8%+3.9%+5.4%+5.5%+3.7%
Q1 2025+73.5%+9.9%+8.4%+9.0%+5.5%
Q2 2025+76.4%+4.9%+7.8%+7.6%+2.3%
Q3 2025+73.8%+2.0%+2.6%+2.7%+0.7%
Q4 2025+71.9%+1.5%+3.3%+3.8%+1.0%
Q1 2026+49.4%-2.7%-15.1%-20.6%-4.1%
Q2 2026+63.8%-12.9%-11.5%-26.6%-2.4%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$165.5M$11.4M-$154.2M2.14
Q4 2024$220.6M$11.3M-$209.2M1.79
Q1 2025$273.7M$63.4M-$210.4M1.59
Q2 2025$1.1B$1B-$80.2M4.98
Q3 2025$345.8M$1.1B$772.2M1.88
Q4 2025$228.6M$1.1B$892M1.90
Q1 2026$222.3M$1.1B$909.8M1.69
Q2 2026$609.8M$1.5B$936.4M0.93
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$4B$3.8B9.913.2
Q4 2024$5.3B$5.1B11.050.4
Q1 2025$6.6B$6.3B11.233.6
Q2 2025$11.2B$11.1B20.565.6
Q3 2025$12.8B$13.6B21.4202.6
Q4 2025$7.4B$8.3B11.990.2
Q1 2026$4.7B$5.7B7.8-13.0
Q2 2026$8B$9B10.7-23.4
Refreshed 3h ago
Charts: revenue, profit, cash flow & valuation
CashDebt
Gross marginOperating marginNet margin
P/EP/S
CashDebt
Gross marginOperating marginNet margin
P/EP/S
Next catalyst
Catalysts
Next catalyst
Catalysts
Earnings
2026-11-09
Revenue est. $892.6M · Updated 3h ago
No unusual perp activity right now.
FMP reference data
Market context
FMP reference data
Market context
New York Stock Exchange
After-hours reference
Bid28.5
Ask28.85
Volume6,524,603
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6DateEPS estimateRevenue estimateGrowthAnalysts
FY 2026-0.59$3.2B+37%8
FY 20270.30$4B+72%9
FY 20280.69$4.6B+96%7
FY 20290.78$5B+112%2
FY 20300.85$4.6B+98%4
Q1 2027-0.01$895.5M+47%2
Company events
62026-11-09EarningsActual - / Estimate 0.07-
2026-08-10Earnings · After market closeActual -0.37 / Estimate -0.05Miss
2026-05-11EarningsActual -0.4 / Estimate 0.03Miss
2026-02-23EarningsActual 0.07 / Estimate 0.02Beat
2025-11-03EarningsActual 0.06 / Estimate 0.09Miss
2025-08-04EarningsActual 0.17 / Estimate 0.18Miss
Peer comparison
Similar listed perpsRevenue mix
PendingSegment data is not available yet.
Analysts
PendingNo analyst data available yet.
Ownership
HIMS-PERPOwnership data is being populated.
Filings
PendingNo filings available yet.
Company news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.No articles from Reuters, WSJ, Bloomberg or FT for this company in our feed.
FMP company data
Company intelligence
Updated: Sep 18, 2026, 06:21 AM UTC
FMP company data
Company intelligence
Company profile
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Chief executive
- Andrew Dudum
- Employees
- 2,442
- IPO date
- Sep 13, 2019
- Country
- US
- Exchange
- New York Stock Exchange
Altman Z-scorei1.54
Piotroski scorei2/9
FMP ratingiC
Owner earningsi-$33.23M-$0.14 per share
ESG risk ratingiBIndustry rank: 12 out of 78
Rating factors
- Return on equityi
- 1
- Return on assetsi
- 1
- Debt to equityi
- 1
- Price to earningsi
- 1
- Price to booki
- 1
Company press releases
HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP AnnouncesBusiness WireHims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit Before November 2, 2026 DeadlinePRNewsWireKaplan Fox Notifies Investors of Hims & Hers Health, Inc. (HIMS) of the Lead Plaintiff Deadline on November 2, 2026Newsfile CorpHims & Hers Health, Inc. (HIMS) Investors: November 2, 2026, Deadline in Securities Fraud Class Action LawsuitPRNewsWireHIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud LawsuitPRNewsWireHims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMSGlobeNewsWire
Congressional disclosures
Market cap history
$6.48B-11.0%Jun 26 – Sep 26
Latest: $6.48B · 2026-09-17High: $8.74B · 2026-07-06Low: $6.48B · 2026-09-17
Largest fund holders
| Fund | Weight | Shares held |
|---|---|---|
| IJH | 0.17% | 7.4M |
| XAW.TO | 0.01% | 7.4M |
| NJH | 0.17% | 7M |
| VTI | 0.01% | 6.7M |
| IWM | 0.2% | 5.7M |
| VB | 0.08% | 4.9M |
| NJM | 0.17% | 4.8M |
| FSSNX | 0.23% | 2.9M |
| VBK | 0.18% | 2.8M |
| VXF | 0.07% | 2.5M |
| IWO | 0.4% | 2M |
| NLO | 0.32% | 1.7M |
Analyst track record
How the analysts covering HIMS have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 138 | 370 |
| Analysts | 19 | 26 |
| Buy / hold / sell | 26 / 88 / 24 | 95 / 207 / 68 |
| Upgrades / downgrades / initiations | 5 / 1 / 5 | 6 / 9 / 12 |
| Price targets hit / missed | 48 / 65 (42%) | 182 / 146 (55%) |
| Avg. return after a rating (TipRanks) | +2.9% | +17.2% |
| Best / worst call | +134.2% / -65.6% | +318.3% / -65.6% |
After buy calls on this stock: median 21-day move +4.2% vs S&P 500 +0.9% (n = 96)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- Jonna KimTD Cowen100% hit rate on this stock · 8 targets measuredHoldtarget $30.00Aug 11, 2026
- Daniel GrosslightCiti95% hit rate on this stock · 22 targets measuredHoldtarget $33.00Aug 12, 2026
- Allen LutzBank of America Securities86% hit rate on this stock · 43 targets measuredHoldtarget $32.00Sep 25, 2026
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Sep 25, 2026 | Allen LutzBank of America Securities | HoldReiterated | $32.00 | article ↗ |
| Sep 25, 2026 | Allen LutzBank of America Securities | HoldReiterated | $32.00 | |
| Sep 15, 2026 | Allen LutzBank of America Securities | HoldMaintained | $32.00 | article ↗ |
| Sep 15, 2026 | Allen LutzBank of America Securities | HoldMaintained | $32.00 | |
| Sep 11, 2026 | Jailendra SinghTruist Financial | HoldReiterated | $32.00 | article ↗ |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data via FMP · computed Sep 25, 2026 · 138 ratings
Frequently asked questions
Where can I trade HIMS perpetual futures?
Hims & Hers Health, Inc. (HIMS) perpetual futures trade on 18 crypto venues, including LBank, Binance, Ourbit. PerpEquities compares them by live price, funding rate, open interest and liquidity.
Can I trade HIMS around the clock?
Yes. Unlike the underlying stock, HIMS perpetuals trade 24/7 — including weekends and outside regular market hours.
What is the funding rate on HIMS perpetuals?
Right now the HIMS perp funding rate is +12.0% annualized (venue median), ranging from +12.0% to +12.0% across 18 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.
How does the HIMS perp price compare to the Hims & Hers Health, Inc. stock?
The venue-median HIMS perp mark is $28.8 versus a reference stock price of $28.8, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
What is a HIMS perpetual future?
A HIMS perpetual is a derivative that tracks the price of Hims & Hers Health, Inc. with no expiry date. It lets you take long or short exposure to Hims & Hers Health, Inc. on crypto venues, around the clock.
What is HIMSUSDT perpetual?
HIMSUSDT is the symbol most crypto exchanges use for the Hims & Hers Health, Inc. perpetual settled in USDT (Tether). It tracks the HIMS share price through an index, trades 24/7 with leverage and never expires.
Embed this asset
<a href="https://perpequities.com/stocks/hims-perp"><img src="https://perpequities.com/badge/hims-perp.svg" width="240" height="64" alt="HIMS perpetuals · perpequities.com" loading="lazy"></a>